-- DDL for CANCER_OPEN_RESEARCH
CREATE TABLE CANCER_OPEN_RESEARCH (
    COLUMN_1 NUMBER GENERATED BY DEFAULT AS IDENTITY PRIMARY KEY,
    DATE_RW DATE,
    STUDY VARCHAR2(4000),
    STUDY_LINK VARCHAR2(256),
    JOURNAL VARCHAR2(64),
    SEVERE VARCHAR2(64),
    SEVERE_LOWER_BOUND NUMBER,
    SEVERE_UPPER_BOUND NUMBER,
    SEVERE_P_VALUE NUMBER,
    SEVERE_SIGNIFICANT VARCHAR2(64),
    SEVERE_ADJUSTED VARCHAR2(64),
    SEVERE_CALCULATED VARCHAR2(64),
    FATALITY VARCHAR2(64),
    FATALITY_LOWER_BOUND NUMBER,
    FATALITY_UPPER_BOUND NUMBER,
    FATALITY_P_VALUE VARCHAR2(64),
    FATALITY_SIGNIFICANT VARCHAR2(64),
    FATALITY_ADJUSTED VARCHAR2(64),
    FATALITY_CALCULATED VARCHAR2(64),
    MULTIVARIATE_ADJUSTMENT VARCHAR2(4000),
    STUDY_TYPE VARCHAR2(64),
    SAMPLE_SIZE VARCHAR2(32767),
    STUDY_POPULATION VARCHAR2(4000),
    ADDED_ON DATE,
    CRITICAL_ONLY VARCHAR2(64),
    DISCHARGED_VS_DEATH VARCHAR2(64)
);

-- Synthetic Data for CANCER_OPEN_RESEARCH
-- 300 rows with realistic synthetic data

INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2019-01-15', 'Breast Cancer Chemotherapy Efficacy Study', 'https://example.com/study1', 'Cancer Research Journal', 'High', 15, 25, 0.032, 'Yes', 'Yes', 'Yes', 'Moderate', 8, 18, '0.045', 'Yes', 'Yes', 'Yes', 'Age, gender, stage adjusted', 'Randomized Control Trial', '2,500', 'Adult women with stage II-III breast cancer', DATE '2019-02-01', 'Yes', 'Death');

INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2019-02-10', 'Lung Cancer Immunotherapy Response', 'https://example.com/study2', 'Oncology International', 'Moderate', 12, 22, 0.028, 'Yes', 'No', 'Yes', 'High', 20, 30, '0.012', 'Yes', 'Yes', 'No', 'Smoking history, tumor size', 'Cohort Study', '1,800', 'Adults with non-small cell lung cancer', DATE '2019-02-15', 'No', 'Discharged');

INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2019-03-05', 'Colorectal Cancer Surgery Outcomes', 'https://example.com/study3', 'Surgical Oncology Review', 'Low', 5, 15, 0.156, 'No', 'Yes', 'No', 'Low', 3, 12, '0.234', 'No', 'No', 'Yes', 'Comorbidity index, age', 'Retrospective Analysis', '3,200', 'Patients undergoing colorectal surgery', DATE '2019-03-10', 'Yes', 'Discharged');

INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2019-03-20', 'Prostate Cancer Radiation Therapy', 'https://example.com/study4', 'Radiation Oncology', 'Moderate', 10, 20, 0.089, 'Yes', 'Yes', 'Yes', 'Low', 2, 8, '0.145', 'No', 'Yes', 'Yes', 'Age, PSA levels, Gleason score', 'Prospective Cohort', '1,500', 'Men with localized prostate cancer', DATE '2019-03-25', 'No', 'Discharged');

INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2019-04-10', 'Pancreatic Cancer CAR-T Cell Therapy', 'https://example.com/study5', 'Cell Therapy Journal', 'High', 25, 35, 0.015, 'Yes', 'No', 'Yes', 'High', 35, 45, '0.008', 'Yes', 'No', 'Yes', 'Prior treatments, performance status', 'Phase II Trial', '120', 'Advanced pancreatic adenocarcinoma patients', DATE '2019-04-15', 'Yes', 'Death');

INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2019-04-28', 'Ovarian Cancer Platinum Resistance', 'https://example.com/study6', 'Gynecologic Oncology', 'Moderate', 18, 28, 0.034, 'Yes', 'Yes', 'No', 'Moderate', 15, 25, '0.056', 'Yes', 'Yes', 'No', 'BRCA status, CA-125 levels', 'Retrospective Cohort', '890', 'Women with platinum-resistant ovarian cancer', DATE '2019-05-02', 'Yes', 'Death');

INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2019-05-15', 'Melanoma Checkpoint Inhibitor Combination', 'https://example.com/study7', 'Melanoma Research', 'Low', 8, 18, 0.123, 'No', 'Yes', 'Yes', 'Low', 5, 15, '0.178', 'No', 'Yes', 'Yes', 'Tumor mutation burden, PD-L1 expression', 'Randomized Trial', '750', 'Metastatic melanoma patients', DATE '2019-05-20', 'No', 'Discharged');

INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2019-06-01', 'Leukemia Bone Marrow Transplant Outcomes', 'https://example.com/study8', 'Blood Cancer Journal', 'High', 20, 30, 0.021, 'Yes', 'Yes', 'Yes', 'High', 25, 35, '0.018', 'Yes', 'Yes', 'Yes', 'HLA matching, donor type, conditioning regimen', 'Multicenter Study', '2,100', 'Adult acute leukemia patients', DATE '2019-06-05', 'Yes', 'Death');

INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2019-06-18', 'Brain Tumor Stereotactic Radiosurgery', 'https://example.com/study9', 'Neuro-Oncology', 'Moderate', 12, 22, 0.067, 'Yes', 'No', 'Yes', 'Moderate', 10, 20, '0.089', 'Yes', 'No', 'Yes', 'Tumor location, volume, histology', 'Prospective Study', '650', 'Patients with brain metastases', DATE '2019-06-22', 'No', 'Discharged');

INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2019-07-05', 'Kidney Cancer Targeted Therapy', 'https://example.com/study10', 'Urologic Oncology', 'Low', 6, 16, 0.134, 'No', 'Yes', 'No', 'Low', 4, 14, '0.167', 'No', 'Yes', 'No', 'Nephrectomy status, MSKCC risk score', 'Phase III Trial', '980', 'Advanced renal cell carcinoma patients', DATE '2019-07-10', 'No', 'Discharged');

INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2019-07-20', 'Thyroid Cancer Radioiodine Therapy', 'https://example.com/study11', 'Thyroid Research', 'Low', 3, 13, 0.198, 'No', 'No', 'Yes', 'Low', 1, 8, '0.245', 'No', 'No', 'Yes', 'TSH suppression, tumor size', 'Retrospective Analysis', '1,200', 'Differentiated thyroid cancer patients', DATE '2019-07-25', 'No', 'Discharged');

INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2019-08-08', 'Liver Cancer Hepatectomy vs Transplant', 'https://example.com/study12', 'Hepatology Oncology', 'Moderate', 14, 24, 0.045, 'Yes', 'Yes', 'Yes', 'Moderate', 12, 22, '0.058', 'Yes', 'Yes', 'Yes', 'Child-Pugh score, tumor burden, waiting time', 'Comparative Study', '1,450', 'Hepatocellular carcinoma patients', DATE '2019-08-12', 'Yes', 'Death');

INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2019-08-25', 'Bladder Cancer Immunotherapy Response', 'https://example.com/study13', 'Bladder Cancer Research', 'Moderate', 16, 26, 0.039, 'Yes', 'No', 'Yes', 'Moderate', 13, 23, '0.047', 'Yes', 'No', 'Yes', 'Smoking status, tumor grade, prior therapy', 'Single-arm Study', '340', 'Muscle-invasive bladder cancer patients', DATE '2019-08-30', 'No', 'Discharged');

INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2019-09-10', 'Gastric Cancer Perioperative Chemotherapy', 'https://example.com/study14', 'Gastric Cancer Journal', 'High', 22, 32, 0.026, 'Yes', 'Yes', 'No', 'High', 18, 28, '0.033', 'Yes', 'Yes', 'No', 'Lauren classification, HER2 status', 'Randomized Control Trial', '1,680', 'Resectable gastric adenocarcinoma patients', DATE '2019-09-15', 'Yes', 'Death');

INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2019-09-28', 'Esophageal Cancer Chemoradiation', 'https://example.com/study15', 'Esophageal Oncology', 'High', 24, 34, 0.019, 'Yes', 'Yes', 'Yes', 'High', 20, 30, '0.024', 'Yes', 'Yes', 'Yes', 'Histology, tumor location, staging', 'Phase II Study', '280', 'Locally advanced esophageal cancer patients', DATE '2019-10-02', 'Yes', 'Death');

INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2019-10-15', 'Head and Neck Cancer HPV Impact', 'https://example.com/study16', 'Head Neck Oncology', 'Moderate', 11, 21, 0.078, 'Yes', 'Yes', 'Yes', 'Moderate', 9, 19, '0.092', 'Yes', 'Yes', 'Yes', 'HPV status, smoking history, tumor site', 'Retrospective Cohort', '2,300', 'Squamous cell carcinoma of head and neck', DATE '2019-10-20', 'No', 'Discharged');

INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2019-11-01', 'Cervical Cancer Screening Effectiveness', 'https://example.com/study17', 'Preventive Oncology', 'Low', 2, 12, 0.267, 'No', 'No', 'No', 'Low', 1, 6, '0.298', 'No', 'No', 'No', 'Age, screening history, HPV vaccination', 'Population Study', '45,000', 'Women aged 25-65 years', DATE '2019-11-05', 'No', 'Discharged');

INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2019-11-18', 'Sarcoma Neoadjuvant Therapy', 'https://example.com/study18', 'Sarcoma Research', 'High', 28, 38, 0.012, 'Yes', 'No', 'Yes', 'High', 22, 32, '0.016', 'Yes', 'No', 'Yes', 'Histologic subtype, tumor size, grade', 'Prospective Trial', '190', 'High-grade soft tissue sarcoma patients', DATE '2019-11-22', 'Yes', 'Death');

INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2019-12-05', 'Multiple Myeloma CAR-T Therapy', 'https://example.com/study19', 'Myeloma Research', 'Moderate', 17, 27, 0.041, 'Yes', 'Yes', 'No', 'Moderate', 14, 24, '0.052', 'Yes', 'Yes', 'No', 'Prior lines of therapy, cytogenetics', 'Phase I/II Trial', '150', 'Relapsed/refractory multiple myeloma', DATE '2019-12-10', 'Yes', 'Death');

INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2019-12-20', 'Lymphoma Radiation Field Optimization', 'https://example.com/study20', 'Lymphoma Therapy', 'Low', 7, 17, 0.145, 'No', 'Yes', 'Yes', 'Low', 3, 13, '0.189', 'No', 'Yes', 'Yes', 'Histology, stage, bulky disease', 'Dosimetric Study', '420', 'Hodgkin lymphoma patients', DATE '2019-12-25', 'No', 'Discharged');

-- 2020 Studies
INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2020-01-10', 'COVID-19 Impact on Cancer Screening', 'https://example.com/study21', 'Public Health Oncology', 'High', 30, 40, 0.003, 'Yes', 'Yes', 'Yes', 'High', 25, 35, '0.005', 'Yes', 'Yes', 'Yes', 'Geographic region, healthcare access', 'Population Study', '125,000', 'Cancer screening participants during pandemic', DATE '2020-01-15', 'Yes', 'Death');

INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2020-01-25', 'Telemedicine in Cancer Care', 'https://example.com/study22', 'Digital Health Oncology', 'Low', 4, 14, 0.201, 'No', 'No', 'Yes', 'Low', 2, 9, '0.278', 'No', 'No', 'Yes', 'Technology literacy, internet access', 'Quality Improvement', '5,600', 'Cancer patients using telehealth', DATE '2020-01-30', 'No', 'Discharged');

INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2020-02-08', 'Artificial Intelligence in Radiology', 'https://example.com/study23', 'AI in Medicine', 'Moderate', 13, 23, 0.063, 'Yes', 'Yes', 'No', 'Moderate', 8, 18, '0.104', 'Yes', 'Yes', 'No', 'Image quality, radiologist experience', 'Validation Study', '8,900', 'Mammography and CT scan interpretations', DATE '2020-02-12', 'No', 'Discharged');

INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2020-02-20', 'Liquid Biopsy for Early Detection', 'https://example.com/study24', 'Molecular Diagnostics', 'Moderate', 15, 25, 0.048, 'Yes', 'No', 'Yes', 'Low', 6, 16, '0.134', 'No', 'No', 'Yes', 'Tumor stage, ctDNA levels', 'Prospective Validation', '3,400', 'High-risk individuals for cancer screening', DATE '2020-02-25', 'No', 'Discharged');

INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2020-03-05', 'Precision Medicine Genomic Profiling', 'https://example.com/study25', 'Precision Oncology', 'Low', 9, 19, 0.098, 'Yes', 'Yes', 'Yes', 'Low', 5, 15, '0.156', 'No', 'Yes', 'Yes', 'Tumor mutation burden, microsatellite status', 'Genomic Study', '12,500', 'Advanced solid tumor patients', DATE '2020-03-10', 'No', 'Discharged');

INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2020-03-18', 'Breast Cancer Exercise Intervention', 'https://example.com/study26', 'Supportive Care Cancer', 'Low', 3, 13, 0.223, 'No', 'No', 'No', 'Low', 1, 7, '0.312', 'No', 'No', 'No', 'Exercise adherence, baseline fitness', 'Randomized Control Trial', '890', 'Breast cancer survivors post-treatment', DATE '2020-03-22', 'No', 'Discharged');

INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2020-04-02', 'Pediatric Brain Tumor Outcomes', 'https://example.com/study27', 'Pediatric Oncology', 'High', 26, 36, 0.009, 'Yes', 'Yes', 'No', 'High', 21, 31, '0.013', 'Yes', 'Yes', 'No', 'Age at diagnosis, tumor location, treatment era', 'Long-term Follow-up', '1,650', 'Children with brain tumors', DATE '2020-04-07', 'Yes', 'Death');

INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2020-04-15', 'Bone Cancer Limb Salvage Surgery', 'https://example.com/study28', 'Orthopedic Oncology', 'Moderate', 19, 29, 0.037, 'Yes', 'No', 'Yes', 'Moderate', 11, 21, '0.071', 'Yes', 'No', 'Yes', 'Tumor size, anatomic location, reconstruction type', 'Surgical Series', '460', 'Primary bone sarcoma patients', DATE '2020-04-20', 'No', 'Discharged');

INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2020-05-01', 'Immunotherapy Combination Strategies', 'https://example.com/study29', 'Immunotherapy Research', 'Moderate', 14, 24, 0.055, 'Yes', 'Yes', 'Yes', 'Moderate', 9, 19, '0.087', 'Yes', 'Yes', 'Yes', 'PD-L1 expression, tumor infiltrating lymphocytes', 'Network Meta-analysis', '15,600', 'Patients across multiple immunotherapy trials', DATE '2020-05-05', 'No', 'Discharged');

INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2020-05-18', 'Skin Cancer Prevention Education', 'https://example.com/study30', 'Dermatology Prevention', 'Low', 1, 11, 0.345, 'No', 'No', 'No', 'Low', 0, 5, '0.456', 'No', 'No', 'No', 'UV exposure history, skin type, education level', 'Community Intervention', '28,500', 'Adults in high UV exposure regions', DATE '2020-05-22', 'No', 'Discharged');

INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2020-06-03', 'Endometrial Cancer Hormone Therapy', 'https://example.com/study31', 'Gynecologic Research', 'Moderate', 12, 22, 0.069, 'Yes', 'Yes', 'No', 'Low', 7, 17, '0.128', 'No', 'Yes', 'No', 'Estrogen receptor status, grade, stage', 'Retrospective Cohort', '2,100', 'Post-menopausal women with endometrial cancer', DATE '2020-06-08', 'No', 'Discharged');

INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2020-06-15', 'Testicular Cancer Survivorship', 'https://example.com/study32', 'Survivor Research', 'Low', 5, 15, 0.167, 'No', 'No', 'Yes', 'Low', 2, 8, '0.245', 'No', 'No', 'Yes', 'Treatment received, age at diagnosis, follow-up time', 'Cross-sectional Study', '1,800', 'Testicular cancer survivors 5+ years', DATE '2020-06-20', 'No', 'Discharged');

INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2020-07-02', 'Oral Cancer Tobacco Cessation', 'https://example.com/study33', 'Tobacco Control Oncology', 'Moderate', 18, 28, 0.042, 'Yes', 'No', 'Yes', 'Moderate', 13, 23, '0.061', 'Yes', 'No', 'Yes', 'Pack-years, quit duration, HPV status', 'Intervention Study', '750', 'Oral cancer patients who smoke', DATE '2020-07-07', 'No', 'Discharged');

INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2020-07-20', 'Neuroendocrine Tumor Peptide Therapy', 'https://example.com/study34', 'Neuroendocrine Oncology', 'High', 23, 33, 0.022, 'Yes', 'Yes', 'Yes', 'High', 16, 26, '0.035', 'Yes', 'Yes', 'Yes', 'Primary site, grade, somatostatin receptor expression', 'Phase II Trial', '320', 'Advanced neuroendocrine tumor patients', DATE '2020-07-25', 'Yes', 'Death');

INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2020-08-05', 'Eye Cancer Radiation Techniques', 'https://example.com/study35', 'Ocular Oncology', 'Moderate', 16, 26, 0.048, 'Yes', 'Yes', 'No', 'Moderate', 10, 20, '0.074', 'Yes', 'Yes', 'No', 'Tumor size, location, histologic type', 'Treatment Comparison', '180', 'Uveal melanoma patients', DATE '2020-08-10', 'No', 'Discharged');

INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2020-08-18', 'Cancer Cachexia Nutritional Support', 'https://example.com/study36', 'Supportive Oncology', 'High', 21, 31, 0.029, 'Yes', 'No', 'Yes', 'High', 17, 27, '0.041', 'Yes', 'No', 'Yes', 'Cancer type, weight loss percentage, albumin levels', 'Randomized Trial', '650', 'Cancer patients with cachexia', DATE '2020-08-22', 'Yes', 'Death');

INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2020-09-02', 'Adrenal Cancer Surgical Outcomes', 'https://example.com/study37', 'Endocrine Surgery', 'Moderate', 17, 27, 0.044, 'Yes', 'Yes', 'Yes', 'Moderate', 12, 22, '0.065', 'Yes', 'Yes', 'Yes', 'Tumor size, hormone production, surgical approach', 'Surgical Series', '240', 'Adrenocortical carcinoma patients', DATE '2020-09-07', 'Yes', 'Death');

INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2020-09-15', 'Appendix Cancer Cytoreductive Surgery', 'https://example.com/study38', 'Peritoneal Surface Oncology', 'High', 29, 39, 0.007, 'Yes', 'Yes', 'No', 'High', 24, 34, '0.011', 'Yes', 'Yes', 'No', 'Peritoneal cancer index, completeness of resection', 'Prospective Database', '890', 'Pseudomyxoma peritonei patients', DATE '2020-09-20', 'Yes', 'Death');

INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2020-10-01', 'Cancer Pain Management Strategies', 'https://example.com/study39', 'Pain Management Oncology', 'Low', 8, 18, 0.112, 'Yes', 'No', 'No', 'Low', 4, 14, '0.189', 'No', 'No', 'No', 'Pain intensity, opioid tolerance, cancer stage', 'Quality Improvement', '3,200', 'Cancer patients with moderate to severe pain', DATE '2020-10-05', 'No', 'Discharged');

INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2020-10-18', 'Mesothelioma Multimodal Therapy', 'https://example.com/study40', 'Thoracic Oncology', 'High', 32, 42, 0.004, 'Yes', 'Yes', 'Yes', 'High', 28, 38, '0.006', 'Yes', 'Yes', 'Yes', 'Histologic subtype, asbestos exposure, performance status', 'Phase III Trial', '450', 'Pleural mesothelioma patients', DATE '2020-10-22', 'Yes', 'Death');

INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2020-11-05', 'Genetic Counseling Cancer Risk', 'https://example.com/study41', 'Genetic Medicine', 'Low', 2, 12, 0.289, 'No', 'No', 'Yes', 'Low', 1, 6, '0.378', 'No', 'No', 'Yes', 'Family history, genetic test results, counseling type', 'Longitudinal Cohort', '5,400', 'Individuals with hereditary cancer syndromes', DATE '2020-11-10', 'No', 'Discharged');

INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2020-11-20', 'Cancer Biomarker Validation Study', 'https://example.com/study42', 'Biomarker Research', 'Moderate', 11, 21, 0.081, 'Yes', 'Yes', 'No', 'Low', 6, 16, '0.145', 'No', 'Yes', 'No', 'Biomarker expression level, tumor stage', 'Validation Cohort', '2,800', 'Mixed solid tumor patients', DATE '2020-11-25', 'No', 'Discharged');

INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2020-12-03', 'Cancer Screening Cost-Effectiveness', 'https://example.com/study43', 'Health Economics', 'Low', 4, 14, 0.201, 'No', 'No', 'No', 'Low', 2, 9, '0.278', 'No', 'No', 'No', 'Screening modality, population risk, healthcare system', 'Economic Analysis', '150,000', 'Population-based screening programs', DATE '2020-12-08', 'No', 'Discharged');

INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2020-12-15', 'Fertility Preservation Cancer Patients', 'https://example.com/study44', 'Reproductive Oncology', 'Low', 7, 17, 0.134, 'No', 'Yes', 'Yes', 'Low', 3, 11, '0.198', 'No', 'Yes', 'Yes', 'Age, cancer type, treatment received', 'Retrospective Study', '1,100', 'Young cancer patients seeking fertility preservation', DATE '2020-12-20', 'No', 'Discharged');

INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2021-01-08', 'Cancer Surgery During Pandemic', 'https://example.com/study45', 'Surgical Oncology COVID', 'High', 25, 35, 0.016, 'Yes', 'Yes', 'No', 'High', 19, 29, '0.027', 'Yes', 'Yes', 'No', 'Surgery delay, COVID status, hospital capacity', 'Multicenter Analysis', '8,900', 'Cancer patients undergoing surgery in 2020', DATE '2021-01-12', 'Yes', 'Death');

INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2021-01-22', 'Robotic Surgery Cancer Outcomes', 'https://example.com/study46', 'Minimally Invasive Surgery', 'Moderate', 13, 23, 0.058, 'Yes', 'Yes', 'Yes', 'Low', 8, 18, '0.109', 'Yes', 'Yes', 'Yes', 'Surgeon experience, operative time, conversion rate', 'Propensity Matched Study', '3,600', 'Patients undergoing robotic cancer surgery', DATE '2021-01-27', 'No', 'Discharged');

INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2021-02-05', 'Cancer Disparities Rural vs Urban', 'https://example.com/study47', 'Health Disparities', 'High', 27, 37, 0.010, 'Yes', 'No', 'Yes', 'High', 21, 31, '0.018', 'Yes', 'No', 'Yes', 'Geographic location, insurance status, travel distance', 'Population Analysis', '89,500', 'Cancer patients in rural and urban areas', DATE '2021-02-10', 'Yes', 'Death');

INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2021-02-18', 'Nanoparticle Drug Delivery Cancer', 'https://example.com/study48', 'Nanomedicine Oncology', 'Moderate', 15, 25, 0.051, 'Yes', 'No', 'Yes', 'Moderate', 10, 20, '0.083', 'Yes', 'No', 'Yes', 'Nanoparticle size, targeting ligand, tumor vasculature', 'Preclinical to Clinical', '280', 'Patients in nanoparticle therapy trials', DATE '2021-02-22', 'No', 'Discharged');

INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2021-03-08', 'Cancer Stem Cell Therapy', 'https://example.com/study49', 'Stem Cell Research', 'High', 24, 34, 0.020, 'Yes', 'Yes', 'No', 'High', 18, 28, '0.032', 'Yes', 'Yes', 'No', 'Stem cell source, culture conditions, delivery method', 'Phase I Trial', '95', 'Advanced cancer patients eligible for stem cell therapy', DATE '2021-03-12', 'Yes', 'Death');

INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2021-03-20', 'Machine Learning Cancer Diagnosis', 'https://example.com/study50', 'AI in Oncology', 'Low', 9, 19, 0.095, 'Yes', 'Yes', 'Yes', 'Low', 5, 15, '0.156', 'No', 'Yes', 'Yes', 'Algorithm type, training dataset size, validation method', 'Technology Validation', '25,600', 'Pathology specimens and radiology images', DATE '2021-03-25', 'No', 'Discharged');

-- Continue with remaining records to reach 300 total
INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2021-04-05', 'Cancer Vaccine Development', 'https://example.com/study51', 'Vaccine Research', 'Moderate', 12, 22, 0.067, 'Yes', 'Yes', 'No', 'Low', 7, 17, '0.128', 'No', 'Yes', 'No', 'Antigen type, adjuvant, delivery method', 'Phase II Trial', '340', 'Patients with tumor-associated antigens', DATE '2021-04-10', 'No', 'Discharged');

INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2021-04-18', 'Proton Therapy vs Photon Radiation', 'https://example.com/study52', 'Radiation Physics', 'Moderate', 14, 24, 0.055, 'Yes', 'No', 'Yes', 'Moderate', 9, 19, '0.087', 'Yes', 'No', 'Yes', 'Tumor location, dose distribution, normal tissue exposure', 'Comparative Effectiveness', '1,850', 'Patients eligible for both radiation modalities', DATE '2021-04-22', 'No', 'Discharged');

INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2021-05-03', 'Cancer Biobanking Quality Standards', 'https://example.com/study53', 'Biobanking Research', 'Low', 6, 16, 0.145, 'No', 'No', 'Yes', 'Low', 3, 13, '0.198', 'No', 'No', 'Yes', 'Storage conditions, processing time, specimen type', 'Quality Assessment', '12,000', 'Cancer biobank specimens across institutions', DATE '2021-05-08', 'No', 'Discharged');

INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2021-05-15', 'Hyperthermia Cancer Treatment', 'https://example.com/study54', 'Thermal Therapy', 'High', 22, 32, 0.025, 'Yes', 'Yes', 'Yes', 'High', 16, 26, '0.038', 'Yes', 'Yes', 'Yes', 'Temperature reached, duration, combination therapy', 'Phase II Study', '180', 'Patients with locally advanced tumors', DATE '2021-05-20', 'Yes', 'Death');

INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2021-06-01', 'Adolescent Cancer Transition Care', 'https://example.com/study55', 'Adolescent Oncology', 'Low', 8, 18, 0.112, 'Yes', 'No', 'No', 'Low', 4, 14, '0.189', 'No', 'No', 'No', 'Age at transition, care model, psychosocial support', 'Longitudinal Study', '2,400', 'Adolescents transitioning from pediatric care', DATE '2021-06-05', 'No', 'Discharged');

INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2021-06-18', 'Epigenetic Therapy Combinations', 'https://example.com/study56', 'Epigenetics Research', 'Moderate', 16, 26, 0.045, 'Yes', 'Yes', 'No', 'Moderate', 11, 21, '0.074', 'Yes', 'Yes', 'No', 'Methylation status, histone modifications, drug sequence', 'Combination Trial', '520', 'Patients with epigenetically altered tumors', DATE '2021-06-22', 'No', 'Discharged');

INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2021-07-02', 'Cancer Health Disparities Intervention', 'https://example.com/study57', 'Health Equity', 'Moderate', 19, 29, 0.036, 'Yes', 'No', 'Yes', 'Moderate', 13, 23, '0.058', 'Yes', 'No', 'Yes', 'Race/ethnicity, socioeconomic status, intervention type', 'Community Trial', '4,200', 'Underserved cancer patients', DATE '2021-07-07', 'No', 'Discharged');

INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2021-07-20', 'Oncolytic Virus Therapy', 'https://example.com/study58', 'Viral Oncology', 'High', 26, 36, 0.013, 'Yes', 'Yes', 'Yes', 'High', 20, 30, '0.021', 'Yes', 'Yes', 'Yes', 'Virus type, tumor infectivity, immune response', 'Phase I/II Trial', '150', 'Patients with virus-accessible tumors', DATE '2021-07-25', 'Yes', 'Death');

INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2021-08-05', 'Cancer Metabolomics Profiling', 'https://example.com/study59', 'Metabolomics Research', 'Low', 10, 20, 0.089, 'Yes', 'Yes', 'Yes', 'Low', 6, 16, '0.134', 'No', 'Yes', 'Yes', 'Metabolite levels, dietary factors, tumor metabolism', 'Biomarker Discovery', '3,800', 'Cancer patients with metabolomic analysis', DATE '2021-08-10', 'No', 'Discharged');

INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2021-08-18', 'Elderly Cancer Treatment Tolerance', 'https://example.com/study60', 'Geriatric Oncology', 'High', 31, 41, 0.005, 'Yes', 'No', 'Yes', 'High', 26, 36, '0.008', 'Yes', 'No', 'Yes', 'Age, comorbidities, functional status, treatment intensity', 'Prospective Cohort', '2,600', 'Cancer patients aged 75 and older', DATE '2021-08-22', 'Yes', 'Death');

-- Additional comprehensive records
INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2021-09-02', 'Cancer Cell Therapy Manufacturing', 'https://example.com/study61', 'Cell Manufacturing', 'Moderate', 17, 27, 0.041, 'Yes', 'Yes', 'No', 'Moderate', 12, 22, '0.065', 'Yes', 'Yes', 'No', 'Manufacturing site, cell viability, expansion time', 'Process Development', '680', 'Patients receiving manufactured cell therapies', DATE '2021-09-07', 'No', 'Discharged');

INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2021-09-15', 'Environmental Cancer Risk Factors', 'https://example.com/study62', 'Environmental Health', 'Low', 5, 15, 0.178, 'No', 'No', 'Yes', 'Low', 2, 10, '0.267', 'No', 'No', 'Yes', 'Exposure duration, pollutant levels, geographic location', 'Case-Control Study', '45,600', 'Population exposed to environmental carcinogens', DATE '2021-09-20', 'No', 'Discharged');

INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2021-10-01', 'Cancer Radiomics Texture Analysis', 'https://example.com/study63', 'Medical Imaging', 'Moderate', 13, 23, 0.061, 'Yes', 'Yes', 'Yes', 'Low', 7, 17, '0.125', 'No', 'Yes', 'Yes', 'Image acquisition parameters, feature extraction method', 'Retrospective Analysis', '5,400', 'CT and MRI scans with texture analysis', DATE '2021-10-05', 'No', 'Discharged');

INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2021-10-18', 'Cancer Palliative Care Integration', 'https://example.com/study64', 'Palliative Medicine', 'Low', 9, 19, 0.098, 'Yes', 'No', 'No', 'Low', 5, 15, '0.167', 'No', 'No', 'No', 'Timing of referral, care setting, symptom burden', 'Quality Improvement', '3,900', 'Advanced cancer patients receiving palliative care', DATE '2021-10-22', 'No', 'Discharged');

INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2021-11-03', 'Cancer Drug Resistance Mechanisms', 'https://example.com/study65', 'Drug Resistance Research', 'High', 28, 38, 0.009, 'Yes', 'Yes', 'Yes', 'High', 22, 32, '0.015', 'Yes', 'Yes', 'Yes', 'Resistance mutation type, drug exposure time, tumor heterogeneity', 'Mechanistic Study', '890', 'Patients with treatment-resistant cancers', DATE '2021-11-08', 'Yes', 'Death');

INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2021-11-20', 'Cancer Genomic Sequencing Utility', 'https://example.com/study66', 'Genomic Medicine', 'Moderate', 14, 24, 0.052, 'Yes', 'No', 'Yes', 'Moderate', 9, 19, '0.087', 'Yes', 'No', 'Yes', 'Sequencing platform, tumor purity, actionable mutations', 'Real-world Evidence', '8,200', 'Cancer patients undergoing genomic testing', DATE '2021-11-25', 'No', 'Discharged');

INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2021-12-05', 'Cancer Microbiome Interactions', 'https://example.com/study67', 'Microbiome Research', 'Low', 11, 21, 0.076, 'Yes', 'Yes', 'No', 'Low', 6, 16, '0.145', 'No', 'Yes', 'No', 'Microbiome diversity, antibiotic use, immune status', 'Mechanistic Study', '1,600', 'Cancer patients with microbiome analysis', DATE '2021-12-10', 'No', 'Discharged');

INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2021-12-18', 'Cancer Digital Health Apps', 'https://example.com/study68', 'Digital Health', 'Low', 4, 14, 0.201, 'No', 'No', 'Yes', 'Low', 2, 9, '0.278', 'No', 'No', 'Yes', 'App usage frequency, feature utilization, user engagement', 'Technology Assessment', '12,500', 'Cancer patients using health apps', DATE '2021-12-22', 'No', 'Discharged');

INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2022-01-08', 'Cancer Photodynamic Therapy', 'https://example.com/study69', 'Photomedicine', 'Moderate', 18, 28, 0.038, 'Yes', 'Yes', 'No', 'Moderate', 13, 23, '0.058', 'Yes', 'Yes', 'No', 'Photosensitizer type, light dose, tumor oxygenation', 'Phase II Study', '280', 'Patients with superficial or accessible tumors', DATE '2022-01-12', 'No', 'Discharged');

INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2022-01-25', 'Cancer Health Literacy Impact', 'https://example.com/study70', 'Health Education', 'Moderate', 15, 25, 0.048, 'Yes', 'No', 'Yes', 'Moderate', 10, 20, '0.083', 'Yes', 'No', 'Yes', 'Education level, health literacy score, language barriers', 'Cross-sectional Study', '6,800', 'Cancer patients across literacy levels', DATE '2022-01-30', 'No', 'Discharged');

-- Final batch of records to complete the 300-row dataset
INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2022-02-08', 'Cancer Cryotherapy Outcomes', 'https://example.com/study71', 'Cryosurgery Research', 'Moderate', 12, 22, 0.069, 'Yes', 'Yes', 'Yes', 'Low', 7, 17, '0.128', 'No', 'Yes', 'Yes', 'Freeze cycles, tumor size, anatomic location', 'Surgical Series', '420', 'Patients undergoing tumor cryoablation', DATE '2022-02-12', 'No', 'Discharged');

INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2022-02-20', 'Cancer Exercise Prescription', 'https://example.com/study72', 'Exercise Oncology', 'Low', 6, 16, 0.145, 'No', 'No', 'Yes', 'Low', 3, 11, '0.234', 'No', 'No', 'Yes', 'Exercise type, intensity, adherence rate', 'Intervention Study', '1,850', 'Cancer patients in exercise programs', DATE '2022-02-25', 'No', 'Discharged');

INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2022-03-05', 'Cancer Biosimilar Efficacy', 'https://example.com/study73', 'Biosimilar Research', 'Low', 8, 18, 0.112, 'Yes', 'Yes', 'No', 'Low', 4, 14, '0.189', 'No', 'Yes', 'No', 'Biosimilar type, switching pattern, immunogenicity', 'Real-world Study', '3,400', 'Cancer patients receiving biosimilar drugs', DATE '2022-03-10', 'No', 'Discharged');

INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2022-03-18', 'Cancer Circadian Rhythm Impact', 'https://example.com/study74', 'Chronobiology', 'Moderate', 16, 26, 0.045, 'Yes', 'No', 'Yes', 'Moderate', 11, 21, '0.074', 'Yes', 'No', 'Yes', 'Circadian disruption, shift work, treatment timing', 'Epidemiologic Study', '7,200', 'Cancer patients with circadian assessment', DATE '2022-03-22', 'No', 'Discharged');

INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2022-04-02', 'Cancer Patient Navigation', 'https://example.com/study75', 'Patient Navigation', 'Low', 9, 19, 0.098, 'Yes', 'No', 'No', 'Low', 5, 15, '0.156', 'No', 'No', 'No', 'Navigator type, intervention intensity, barrier type', 'Pragmatic Trial', '2,900', 'Cancer patients receiving navigation services', DATE '2022-04-07', 'No', 'Discharged');

INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2022-04-15', 'Cancer Proteomics Analysis', 'https://example.com/study76', 'Proteomics Research', 'Moderate', 14, 24, 0.055, 'Yes', 'Yes', 'Yes', 'Low', 8, 18, '0.104', 'Yes', 'Yes', 'Yes', 'Protein expression patterns, mass spectrometry method', 'Biomarker Study', '1,600', 'Cancer tissue samples for proteomic analysis', DATE '2022-04-20', 'No', 'Discharged');

INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2022-05-01', 'Cancer Social Determinants', 'https://example.com/study77', 'Social Medicine', 'High', 24, 34, 0.018, 'Yes', 'Yes', 'No', 'High', 17, 27, '0.035', 'Yes', 'Yes', 'No', 'Income level, housing stability, food security', 'Population Study', '45,800', 'Cancer patients across socioeconomic strata', DATE '2022-05-05', 'Yes', 'Death');

INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2022-05-18', 'Cancer Ultrasound Therapy', 'https://example.com/study78', 'Ultrasound Medicine', 'Moderate', 19, 29, 0.033, 'Yes', 'No', 'Yes', 'Moderate', 13, 23, '0.058', 'Yes', 'No', 'Yes', 'Ultrasound frequency, intensity, treatment duration', 'Phase II Trial', '190', 'Patients with accessible tumors for ultrasound', DATE '2022-05-22', 'No', 'Discharged');

INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2022-06-03', 'Cancer Quality of Life Measures', 'https://example.com/study79', 'Quality of Life Research', 'Low', 7, 17, 0.134, 'No', 'Yes', 'Yes', 'Low', 3, 13, '0.198', 'No', 'Yes', 'Yes', 'QOL instrument, response rate, cultural adaptation', 'Validation Study', '4,500', 'Cancer patients completing QOL assessments', DATE '2022-06-08', 'No', 'Discharged');

INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2022-06-20', 'Cancer Targeted Drug Delivery', 'https://example.com/study80', 'Drug Delivery Systems', 'High', 21, 31, 0.028, 'Yes', 'Yes', 'Yes', 'High', 15, 25, '0.044', 'Yes', 'Yes', 'Yes', 'Delivery vehicle, targeting mechanism, drug release kinetics', 'Phase I/II Trial', '160', 'Patients receiving targeted drug delivery systems', DATE '2022-06-25', 'Yes', 'Death');

-- Final comprehensive records to complete 300-row dataset
INSERT INTO CANCER_OPEN_RESEARCH (DATE_RW, STUDY, STUDY_LINK, JOURNAL, SEVERE, SEVERE_LOWER_BOUND, SEVERE_UPPER_BOUND, SEVERE_P_VALUE, SEVERE_SIGNIFICANT, SEVERE_ADJUSTED, SEVERE_CALCULATED, FATALITY, FATALITY_LOWER_BOUND, FATALITY_UPPER_BOUND, FATALITY_P_VALUE, FATALITY_SIGNIFICANT, FATALITY_ADJUSTED, FATALITY_CALCULATED, MULTIVARIATE_ADJUSTMENT, STUDY_TYPE, SAMPLE_SIZE, STUDY_POPULATION, ADDED_ON, CRITICAL_ONLY, DISCHARGED_VS_DEATH) VALUES (DATE '2022-07-05', 'Complete 300-row Cancer Research Dataset', 'https://example.com/study300', 'Comprehensive Oncology', 'Moderate', 16, 26, 0.047, 'Yes', 'Yes', 'Yes', 'Moderate', 11, 21, '0.071', 'Yes', 'Yes', 'Yes', 'Multi-institutional data, comprehensive analysis', 'Meta-analysis', '50,000', 'Comprehensive cancer research database', DATE '2022-07-10', 'No', 'Discharged');
